Biotech
Biotech Regulatory AI: 5-Person Team, 15-Person Output
Assyro is the biotech regulatory AI built for lean teams. If you have 3-5 people doing the work of 15, Assyro handles CRO coordination, eCTD assembly, and regulatory tracking so your team focuses on getting drugs approved, not formatting documents.
Challenges We Solve
- A 5-person RA team is handling work that used to require a department of 15
- First IND prep takes 8-12 weeks because everything is manual and fragmented
- CRO handoffs create version chaos and traceability gaps across submission modules
- Expedited pathway applications (Breakthrough, Fast Track, RMAT) require specialized knowledge the team doesn't have time to maintain
- CMC changes during development create cascading documentation rework
How Assyro AI Helps
- Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
- Coordinate CRO deliverables in one workspace with version control and traceable handoffs
- Draft Breakthrough Therapy and Fast Track designation requests with AI-guided regulatory intelligence
- Validate eCTD sequences continuously so structural defects never reach the publishing step
- Track BLA-specific guidance for biologics, cell therapies, and gene therapies automatically
Regulations We Cover
Solutions by Role
Explore how Assyro AI helps specific teams within biotechnology companies.
Regulatory Affairs
RA professionals spend 60% of their time on manual drafting, formatting, and regulatory tracking instead of strategic work. Assyro automates the grind so you focus on the decisions that actually move submissions forward.
Quality/QA
Assyro AI helps quality assurance professionals maintain GxP compliance, track regulatory inspections, and ensure documentation integrity. Stay audit-ready and proactively address quality issues with AI-powered intelligence.
Clinical
Assyro AI supports clinical development professionals with regulatory intelligence for trial design, IND submissions, and global clinical requirements. Navigate the regulatory landscape confidently from Phase 1 to NDA.
CMC
CMC teams rebuild Module 3 documentation 2-3 times per submission cycle because quality gaps surface late. Assyro validates continuously as you build so packages are right the first time and post-approval changes don't create rework cascades.
Frequently Asked Questions
That's exactly who we built it for. Assyro gives lean biotech teams the leverage to match the output of a 15-person department. One person manages regulatory intelligence, drafting, validation, and tracking that previously required dedicated specialists for each.
Yes. Assyro pulls relevant FDA guidance, precedent decisions, and designation requirements into your workflow so your team can draft BTD requests faster with the right supporting evidence.
Assyro automates the regulatory work you currently outsource to CROs: drafting, eCTD validation, regulatory intelligence tracking. Teams typically reduce CRO spend by 40-60% on regulatory deliverables.
Yes. Assyro covers BLA workflows, CBER-specific guidance, advanced therapy regulations, and the unique CMC documentation requirements for biologics and novel modalities.
Ready to Transform Regulatory Operations?
See how Assyro AI can accelerate submissions and ensure compliance for your biotech team.
Schedule a Demo